A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

Clinical trial NCT01099709 · COMPLETED

Trial details

NCT number: NCT01099709
Sponsor: Purdue Pharma LP
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2007-01-01
Primary completion: 2007-03-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.